Administrative and Protocol Management Core

行政和礼宾管理核心

• 批准号: 7898238
• 负责人: Sharon L. Hillier
• 金额: $ 17.07万
• 依托单位: MAGEE-WOMEN'S RES INST AND FOUNDATION
• 依托单位国家: 美国
• 财政年份: 2010
• 资助国家: 美国
• 起止时间: 2010-06-15 至 2015-05-31
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/7898238
• 关键词: Acquired Immunodeficiency Syndrome; Agreement; Annual Reports; Basic Science; Budgets; Businesses; Charge; Clinical; Clinical Research; Collaborations; Data; Development; Drug Formulations; Ensure; Expenditure; Film; Goals; Grant; HIV; Human Resources; Individual; Institution; Journals; Lead; Local Microbicides; Modification; National Institute of Allergy and Infectious Disease; New York; Participant; Peer Review; Pharmaceutical Preparations; Play; Process; Protocols documentation; Recommendation; Reporting; Research; Research Ethics Committees; Research Personnel; Rights; Role; Schedule; Scientist; Tenofovir; U-Series Cooperative Agreements; UC 781; United States National Institutes of Health; Universities; Washington; Work; Writing; data sharing; meetings; member; microbicide; pre-clinical; programs; protocol development; symposium

The Administrafive and Protocol Management Core (Core A) of this grant will provide administrative support for the four scientific projects and two scientific cores for the program entitled, "Alternative Formulations of Tenofovir and UC781". Specifically, the Administrafive Core will 1) provide administrafive oversight of the scientific projects and cores in this program, 2) provide fiscal oversight and coordinafion for the program across all projects and cores, 3) be the primary point of contact between this research program and the NIAID Program Officer in charge ofthe Integrated Preclinical/Clinical Program for HIV Topical Microbicides, 4) plan and coordinate monthly conference calls for the Scientific Steering Committee, 5) establish a Scientific Advisory Panel of outside scientists to attend an annual meeting of the Scientific Steering Committee and NIAID program scientists, and 6) assist Core C with coordinafion of research activifies with corporate partners and CONRAD. In addition, this Core will provide protocol management support for the clinical studies in Projects 3 and 4, and ensure smooth interactions between CONRAD, which holds the proprietary rights to UC781 and tenofovir, the University of Pittsburgh IRB, and the Division of AIDS. This Core, which will be led by Drs. Sharon Hillier and Lisa Rohan, will support all four scientific projects and both scientific cores through the promotion of scientific interactions and collaborafions with other invesfigators engaged in microbicide research.

该赠款的行政和方案管理核心（核心 A）将为题为“替诺福韦和 UC781 的替代制剂”的项目的四个科学项目和两个科学核心提供行政支持。具体而言，行政核心将 1) 提供对 该计划中的科学项目和核心，2) 为该计划的所有项目和核心提供财政监督和协调，3) 成为该研究计划与负责综合临床前/临床计划的 NIAID 计划官员之间的主要联络点。 HIV 局部杀菌剂， 4) 计划和协调科学指导委员会的每月电话会议，5) 建立一个由外部科学家组成的科学顾问小组，参加科学指导委员会和 NIAID 项目科学家的年度会议，以及 6) 协助核心 C 协调研究活动和 企业合作伙伴和 CONRAD。此外，该核心将为项目3和项目4的临床研究提供方案管理支持，并确保拥有UC781和替诺福韦专有权利的CONRAD、匹兹堡大学IRB和艾滋病部门之间的顺利互动。该核心将由博士领导。 Sharon Hillier 和 Lisa Rohan 将通过促进与其他从事杀菌剂研究的研究人员的科学互动和合作来支持所有四个科学项目和两个科学核心。